Rani Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RANI and other ETFs, options, and stocks.

About RANI

Rani Therapeutics Holdings, Inc. engages in the operation of a clinical stage bio-therapeutics company. The company was founded by Mir Imran on February 21, 2012 and is headquartered in San Jose, CA. 

CEO
Talat Imran
CEOTalat Imran
Employees
105
Employees105
Headquarters
San Jose, California
HeadquartersSan Jose, California
Founded
2012
Founded2012
Employees
105
Employees105

RANI Key Statistics

Market cap
179.67M
Market cap179.67M
Price-Earnings ratio
-2.75
Price-Earnings ratio-2.75
Dividend yield
Dividend yield
Average volume
20.32M
Average volume20.32M
High today
$2.60
High today$2.60
Low today
$2.17
Low today$2.17
Open price
$2.43
Open price$2.43
Volume
14.06M
Volume14.06M
52 Week high
$3.87
52 Week high$3.87
52 Week low
$0.387
52 Week low$0.387

Stock Snapshot

The current Rani Therapeutics(RANI) stock price is $2.47, with a market capitalization of 179.67M. The stock trades at a price-to-earnings (P/E) ratio of -2.75.

On 2025-11-05, Rani Therapeutics(RANI) stock moved within a range of $2.17 to $2.60. With shares now at $2.47, the stock is trading +13.9% above its intraday low and -5.0% below the session's peak.

Trading activity shows a volume of 14.06M, compared to an average daily volume of 20.32M.

Over the past 52 weeks, Rani Therapeutics(RANI) stock has traded between a high of $3.87 and a low of $0.39.

Over the past 52 weeks, Rani Therapeutics(RANI) stock has traded between a high of $3.87 and a low of $0.39.

People also own

Based on the portfolios of people who own RANI. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.